nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—lung cancer	0.244	0.706	CbGaD
Sumatriptan—ABCB1—lung cancer	0.102	0.294	CbGaD
Sumatriptan—ABCG2—Topotecan—lung cancer	0.0431	0.101	CbGbCtD
Sumatriptan—ABCG2—Gefitinib—lung cancer	0.0394	0.092	CbGbCtD
Sumatriptan—ABCG2—Teniposide—lung cancer	0.0382	0.0892	CbGbCtD
Sumatriptan—SLCO1B1—Irinotecan—lung cancer	0.0265	0.0618	CbGbCtD
Sumatriptan—ABCG2—Erlotinib—lung cancer	0.0233	0.0544	CbGbCtD
Sumatriptan—ABCG2—Paclitaxel—lung cancer	0.0213	0.0498	CbGbCtD
Sumatriptan—ABCG2—Irinotecan—lung cancer	0.021	0.0491	CbGbCtD
Sumatriptan—ABCG2—Cisplatin—lung cancer	0.0172	0.0401	CbGbCtD
Sumatriptan—ABCG2—Etoposide—lung cancer	0.0169	0.0394	CbGbCtD
Sumatriptan—ABCB1—Topotecan—lung cancer	0.0155	0.0363	CbGbCtD
Sumatriptan—ABCG2—Docetaxel—lung cancer	0.0154	0.036	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—lung cancer	0.0149	0.0347	CbGbCtD
Sumatriptan—ABCB1—Gefitinib—lung cancer	0.0142	0.0332	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—lung cancer	0.014	0.0327	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—lung cancer	0.0115	0.0268	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—lung cancer	0.0111	0.026	CbGbCtD
Sumatriptan—ABCB1—Vinorelbine—lung cancer	0.0109	0.0256	CbGbCtD
Sumatriptan—ABCB1—Crizotinib—lung cancer	0.00871	0.0203	CbGbCtD
Sumatriptan—ABCB1—Gemcitabine—lung cancer	0.00851	0.0199	CbGbCtD
Sumatriptan—ABCB1—Erlotinib—lung cancer	0.0084	0.0196	CbGbCtD
Sumatriptan—ABCB1—Paclitaxel—lung cancer	0.00769	0.018	CbGbCtD
Sumatriptan—ABCB1—Irinotecan—lung cancer	0.00759	0.0177	CbGbCtD
Sumatriptan—ABCB1—Vinblastine—lung cancer	0.00675	0.0158	CbGbCtD
Sumatriptan—ABCB1—Cisplatin—lung cancer	0.00619	0.0144	CbGbCtD
Sumatriptan—ABCB1—Etoposide—lung cancer	0.00608	0.0142	CbGbCtD
Sumatriptan—ABCB1—Docetaxel—lung cancer	0.00556	0.013	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—lung cancer	0.00415	0.00968	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—lung cancer	0.00402	0.00938	CbGbCtD
Sumatriptan—Melatonin—MT3—lung cancer	0.00172	0.575	CrCbGaD
Sumatriptan—Eletriptan—CYP2A6—lung cancer	0.00044	0.147	CrCbGaD
Sumatriptan—Almotriptan—CYP2E1—lung cancer	0.000401	0.134	CrCbGaD
Sumatriptan—Melatonin—CYP1A1—lung cancer	0.000267	0.0893	CrCbGaD
Sumatriptan—Eletriptan—ABCB1—lung cancer	0.000164	0.0548	CrCbGaD
Sumatriptan—Somnolence—Etoposide—lung cancer	4.64e-05	0.000282	CcSEcCtD
Sumatriptan—Cough—Docetaxel—lung cancer	4.64e-05	0.000282	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—lung cancer	4.64e-05	0.000282	CcSEcCtD
Sumatriptan—Epistaxis—Methotrexate—lung cancer	4.62e-05	0.000281	CcSEcCtD
Sumatriptan—Hypersensitivity—Irinotecan—lung cancer	4.62e-05	0.000281	CcSEcCtD
Sumatriptan—Convulsion—Docetaxel—lung cancer	4.6e-05	0.00028	CcSEcCtD
Sumatriptan—Paraesthesia—Paclitaxel—lung cancer	4.59e-05	0.000279	CcSEcCtD
Sumatriptan—Hypertension—Docetaxel—lung cancer	4.59e-05	0.000279	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—lung cancer	4.58e-05	0.000278	CcSEcCtD
Sumatriptan—Dyspnoea—Paclitaxel—lung cancer	4.56e-05	0.000277	CcSEcCtD
Sumatriptan—Somnolence—Paclitaxel—lung cancer	4.55e-05	0.000277	CcSEcCtD
Sumatriptan—Decreased appetite—Etoposide—lung cancer	4.54e-05	0.000276	CcSEcCtD
Sumatriptan—Arthralgia—Docetaxel—lung cancer	4.52e-05	0.000275	CcSEcCtD
Sumatriptan—Chest pain—Docetaxel—lung cancer	4.52e-05	0.000275	CcSEcCtD
Sumatriptan—Myalgia—Docetaxel—lung cancer	4.52e-05	0.000275	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—lung cancer	4.52e-05	0.000275	CcSEcCtD
Sumatriptan—Nausea—Vinorelbine—lung cancer	4.52e-05	0.000275	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Etoposide—lung cancer	4.51e-05	0.000274	CcSEcCtD
Sumatriptan—Body temperature increased—Cisplatin—lung cancer	4.5e-05	0.000274	CcSEcCtD
Sumatriptan—Asthenia—Irinotecan—lung cancer	4.5e-05	0.000274	CcSEcCtD
Sumatriptan—Fatigue—Etoposide—lung cancer	4.5e-05	0.000274	CcSEcCtD
Sumatriptan—Pain—Etoposide—lung cancer	4.46e-05	0.000271	CcSEcCtD
Sumatriptan—Constipation—Etoposide—lung cancer	4.46e-05	0.000271	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—lung cancer	4.45e-05	0.000271	CcSEcCtD
Sumatriptan—Decreased appetite—Paclitaxel—lung cancer	4.45e-05	0.00027	CcSEcCtD
Sumatriptan—Dry mouth—Docetaxel—lung cancer	4.42e-05	0.000269	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—lung cancer	4.42e-05	0.000269	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Paclitaxel—lung cancer	4.42e-05	0.000269	CcSEcCtD
Sumatriptan—Fatigue—Paclitaxel—lung cancer	4.41e-05	0.000268	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—lung cancer	4.4e-05	0.000268	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—lung cancer	4.4e-05	0.000267	CcSEcCtD
Sumatriptan—Asthenia—Gemcitabine—lung cancer	4.38e-05	0.000267	CcSEcCtD
Sumatriptan—Pain—Paclitaxel—lung cancer	4.38e-05	0.000266	CcSEcCtD
Sumatriptan—Constipation—Paclitaxel—lung cancer	4.38e-05	0.000266	CcSEcCtD
Sumatriptan—Confusional state—Docetaxel—lung cancer	4.37e-05	0.000266	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—lung cancer	4.34e-05	0.000264	CcSEcCtD
Sumatriptan—Anaphylactic shock—Docetaxel—lung cancer	4.34e-05	0.000264	CcSEcCtD
Sumatriptan—Oedema—Docetaxel—lung cancer	4.34e-05	0.000264	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—lung cancer	4.33e-05	0.000263	CcSEcCtD
Sumatriptan—Pruritus—Gemcitabine—lung cancer	4.32e-05	0.000263	CcSEcCtD
Sumatriptan—Infection—Docetaxel—lung cancer	4.31e-05	0.000262	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—lung cancer	4.31e-05	0.000262	CcSEcCtD
Sumatriptan—Feeling abnormal—Etoposide—lung cancer	4.3e-05	0.000261	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—lung cancer	4.29e-05	0.000261	CcSEcCtD
Sumatriptan—Diarrhoea—Irinotecan—lung cancer	4.29e-05	0.000261	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Etoposide—lung cancer	4.27e-05	0.000259	CcSEcCtD
Sumatriptan—Shock—Docetaxel—lung cancer	4.27e-05	0.000259	CcSEcCtD
Sumatriptan—Nervous system disorder—Docetaxel—lung cancer	4.25e-05	0.000259	CcSEcCtD
Sumatriptan—Thrombocytopenia—Docetaxel—lung cancer	4.25e-05	0.000258	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—lung cancer	4.24e-05	0.000258	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—lung cancer	4.24e-05	0.000258	CcSEcCtD
Sumatriptan—Tachycardia—Docetaxel—lung cancer	4.23e-05	0.000257	CcSEcCtD
Sumatriptan—Feeling abnormal—Paclitaxel—lung cancer	4.22e-05	0.000256	CcSEcCtD
Sumatriptan—Skin disorder—Docetaxel—lung cancer	4.21e-05	0.000256	CcSEcCtD
Sumatriptan—Hypersensitivity—Cisplatin—lung cancer	4.2e-05	0.000255	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Paclitaxel—lung cancer	4.18e-05	0.000254	CcSEcCtD
Sumatriptan—Diarrhoea—Gemcitabine—lung cancer	4.18e-05	0.000254	CcSEcCtD
Sumatriptan—Dizziness—Irinotecan—lung cancer	4.15e-05	0.000252	CcSEcCtD
Sumatriptan—Urticaria—Etoposide—lung cancer	4.15e-05	0.000252	CcSEcCtD
Sumatriptan—Body temperature increased—Etoposide—lung cancer	4.13e-05	0.000251	CcSEcCtD
Sumatriptan—Abdominal pain—Etoposide—lung cancer	4.13e-05	0.000251	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—lung cancer	4.13e-05	0.000251	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—lung cancer	4.11e-05	0.00025	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—lung cancer	4.1e-05	0.000249	CcSEcCtD
Sumatriptan—Asthenia—Cisplatin—lung cancer	4.09e-05	0.000249	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—lung cancer	4.07e-05	0.000247	CcSEcCtD
Sumatriptan—Urticaria—Paclitaxel—lung cancer	4.06e-05	0.000247	CcSEcCtD
Sumatriptan—Hypotension—Docetaxel—lung cancer	4.05e-05	0.000246	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—lung cancer	4.05e-05	0.000246	CcSEcCtD
Sumatriptan—Abdominal pain—Paclitaxel—lung cancer	4.04e-05	0.000246	CcSEcCtD
Sumatriptan—Body temperature increased—Paclitaxel—lung cancer	4.04e-05	0.000246	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—lung cancer	4e-05	0.000243	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—lung cancer	3.99e-05	0.000243	CcSEcCtD
Sumatriptan—Vomiting—Irinotecan—lung cancer	3.99e-05	0.000243	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—lung cancer	3.98e-05	0.000242	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—lung cancer	3.97e-05	0.000242	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—lung cancer	3.97e-05	0.000241	CcSEcCtD
Sumatriptan—Rash—Irinotecan—lung cancer	3.96e-05	0.000241	CcSEcCtD
Sumatriptan—Dermatitis—Irinotecan—lung cancer	3.95e-05	0.00024	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Docetaxel—lung cancer	3.95e-05	0.00024	CcSEcCtD
Sumatriptan—Chills—Methotrexate—lung cancer	3.95e-05	0.00024	CcSEcCtD
Sumatriptan—Headache—Irinotecan—lung cancer	3.93e-05	0.000239	CcSEcCtD
Sumatriptan—Diarrhoea—Cisplatin—lung cancer	3.9e-05	0.000237	CcSEcCtD
Sumatriptan—Paraesthesia—Docetaxel—lung cancer	3.89e-05	0.000237	CcSEcCtD
Sumatriptan—Vomiting—Gemcitabine—lung cancer	3.89e-05	0.000236	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—lung cancer	3.88e-05	0.000236	CcSEcCtD
Sumatriptan—Dyspnoea—Docetaxel—lung cancer	3.87e-05	0.000235	CcSEcCtD
Sumatriptan—Somnolence—Docetaxel—lung cancer	3.86e-05	0.000234	CcSEcCtD
Sumatriptan—Rash—Gemcitabine—lung cancer	3.85e-05	0.000234	CcSEcCtD
Sumatriptan—Dermatitis—Gemcitabine—lung cancer	3.85e-05	0.000234	CcSEcCtD
Sumatriptan—Hypersensitivity—Etoposide—lung cancer	3.84e-05	0.000234	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—lung cancer	3.83e-05	0.000233	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—lung cancer	3.83e-05	0.000233	CcSEcCtD
Sumatriptan—Headache—Gemcitabine—lung cancer	3.83e-05	0.000233	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—lung cancer	3.81e-05	0.000232	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—lung cancer	3.79e-05	0.00023	CcSEcCtD
Sumatriptan—Decreased appetite—Docetaxel—lung cancer	3.77e-05	0.000229	CcSEcCtD
Sumatriptan—Hypersensitivity—Paclitaxel—lung cancer	3.77e-05	0.000229	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—lung cancer	3.75e-05	0.000228	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Docetaxel—lung cancer	3.74e-05	0.000228	CcSEcCtD
Sumatriptan—Asthenia—Etoposide—lung cancer	3.74e-05	0.000228	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—lung cancer	3.74e-05	0.000228	CcSEcCtD
Sumatriptan—Fatigue—Docetaxel—lung cancer	3.74e-05	0.000227	CcSEcCtD
Sumatriptan—Nausea—Irinotecan—lung cancer	3.73e-05	0.000227	CcSEcCtD
Sumatriptan—Constipation—Docetaxel—lung cancer	3.71e-05	0.000226	CcSEcCtD
Sumatriptan—Pain—Docetaxel—lung cancer	3.71e-05	0.000226	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—lung cancer	3.7e-05	0.000225	CcSEcCtD
Sumatriptan—Pruritus—Etoposide—lung cancer	3.69e-05	0.000225	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—lung cancer	3.67e-05	0.000223	CcSEcCtD
Sumatriptan—Asthenia—Paclitaxel—lung cancer	3.67e-05	0.000223	CcSEcCtD
Sumatriptan—Nausea—Gemcitabine—lung cancer	3.63e-05	0.000221	CcSEcCtD
Sumatriptan—Vomiting—Cisplatin—lung cancer	3.62e-05	0.00022	CcSEcCtD
Sumatriptan—Pruritus—Paclitaxel—lung cancer	3.62e-05	0.00022	CcSEcCtD
Sumatriptan—Rash—Cisplatin—lung cancer	3.59e-05	0.000218	CcSEcCtD
Sumatriptan—Dermatitis—Cisplatin—lung cancer	3.59e-05	0.000218	CcSEcCtD
Sumatriptan—Feeling abnormal—Docetaxel—lung cancer	3.57e-05	0.000217	CcSEcCtD
Sumatriptan—Diarrhoea—Etoposide—lung cancer	3.57e-05	0.000217	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—lung cancer	3.56e-05	0.000216	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—lung cancer	3.55e-05	0.000216	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—lung cancer	3.55e-05	0.000216	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Docetaxel—lung cancer	3.55e-05	0.000216	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—lung cancer	3.54e-05	0.000215	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—lung cancer	3.54e-05	0.000215	CcSEcCtD
Sumatriptan—Diarrhoea—Paclitaxel—lung cancer	3.5e-05	0.000213	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—lung cancer	3.46e-05	0.00021	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—lung cancer	3.45e-05	0.00021	CcSEcCtD
Sumatriptan—Dizziness—Etoposide—lung cancer	3.45e-05	0.00021	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—lung cancer	3.44e-05	0.000209	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—lung cancer	3.44e-05	0.000209	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—lung cancer	3.43e-05	0.000209	CcSEcCtD
Sumatriptan—Abdominal pain—Docetaxel—lung cancer	3.43e-05	0.000208	CcSEcCtD
Sumatriptan—Body temperature increased—Docetaxel—lung cancer	3.43e-05	0.000208	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—lung cancer	3.42e-05	0.000208	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—lung cancer	3.4e-05	0.000207	CcSEcCtD
Sumatriptan—Dizziness—Paclitaxel—lung cancer	3.38e-05	0.000206	CcSEcCtD
Sumatriptan—Nausea—Cisplatin—lung cancer	3.38e-05	0.000206	CcSEcCtD
Sumatriptan—Cough—Methotrexate—lung cancer	3.34e-05	0.000203	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—lung cancer	3.32e-05	0.000202	CcSEcCtD
Sumatriptan—Vomiting—Etoposide—lung cancer	3.32e-05	0.000202	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—lung cancer	3.32e-05	0.000202	CcSEcCtD
Sumatriptan—Rash—Etoposide—lung cancer	3.29e-05	0.0002	CcSEcCtD
Sumatriptan—Dermatitis—Etoposide—lung cancer	3.29e-05	0.0002	CcSEcCtD
Sumatriptan—Headache—Etoposide—lung cancer	3.27e-05	0.000199	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—lung cancer	3.27e-05	0.000199	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—lung cancer	3.26e-05	0.000198	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—lung cancer	3.26e-05	0.000198	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—lung cancer	3.26e-05	0.000198	CcSEcCtD
Sumatriptan—Vomiting—Paclitaxel—lung cancer	3.25e-05	0.000198	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—lung cancer	3.25e-05	0.000197	CcSEcCtD
Sumatriptan—Rash—Paclitaxel—lung cancer	3.23e-05	0.000196	CcSEcCtD
Sumatriptan—Dermatitis—Paclitaxel—lung cancer	3.22e-05	0.000196	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—lung cancer	3.22e-05	0.000196	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—lung cancer	3.21e-05	0.000195	CcSEcCtD
Sumatriptan—Headache—Paclitaxel—lung cancer	3.21e-05	0.000195	CcSEcCtD
Sumatriptan—Hypersensitivity—Docetaxel—lung cancer	3.2e-05	0.000194	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—lung cancer	3.19e-05	0.000194	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—lung cancer	3.15e-05	0.000192	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—lung cancer	3.13e-05	0.00019	CcSEcCtD
Sumatriptan—Asthenia—Docetaxel—lung cancer	3.11e-05	0.000189	CcSEcCtD
Sumatriptan—Infection—Methotrexate—lung cancer	3.11e-05	0.000189	CcSEcCtD
Sumatriptan—Nausea—Etoposide—lung cancer	3.1e-05	0.000188	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—lung cancer	3.08e-05	0.000187	CcSEcCtD
Sumatriptan—Pruritus—Docetaxel—lung cancer	3.07e-05	0.000187	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—lung cancer	3.07e-05	0.000186	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—lung cancer	3.07e-05	0.000186	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—lung cancer	3.06e-05	0.000186	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—lung cancer	3.05e-05	0.000185	CcSEcCtD
Sumatriptan—Nausea—Paclitaxel—lung cancer	3.04e-05	0.000185	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—lung cancer	3.04e-05	0.000185	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—lung cancer	3.02e-05	0.000184	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—lung cancer	2.99e-05	0.000182	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—lung cancer	2.98e-05	0.000181	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—lung cancer	2.97e-05	0.000181	CcSEcCtD
Sumatriptan—Diarrhoea—Docetaxel—lung cancer	2.97e-05	0.00018	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—lung cancer	2.93e-05	0.000178	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—lung cancer	2.92e-05	0.000178	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—lung cancer	2.91e-05	0.000177	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—lung cancer	2.89e-05	0.000176	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—lung cancer	2.87e-05	0.000175	CcSEcCtD
Sumatriptan—Dizziness—Docetaxel—lung cancer	2.87e-05	0.000174	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—lung cancer	2.86e-05	0.000174	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—lung cancer	2.85e-05	0.000173	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—lung cancer	2.82e-05	0.000172	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—lung cancer	2.82e-05	0.000172	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—lung cancer	2.82e-05	0.000172	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—lung cancer	2.81e-05	0.000171	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—lung cancer	2.81e-05	0.000171	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—lung cancer	2.79e-05	0.00017	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—lung cancer	2.79e-05	0.000169	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—lung cancer	2.78e-05	0.000169	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—lung cancer	2.76e-05	0.000168	CcSEcCtD
Sumatriptan—Vomiting—Docetaxel—lung cancer	2.76e-05	0.000168	CcSEcCtD
Sumatriptan—Rash—Docetaxel—lung cancer	2.73e-05	0.000166	CcSEcCtD
Sumatriptan—Dermatitis—Docetaxel—lung cancer	2.73e-05	0.000166	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—lung cancer	2.73e-05	0.000166	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—lung cancer	2.72e-05	0.000165	CcSEcCtD
Sumatriptan—Headache—Docetaxel—lung cancer	2.72e-05	0.000165	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—lung cancer	2.71e-05	0.000165	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—lung cancer	2.71e-05	0.000165	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—lung cancer	2.7e-05	0.000164	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—lung cancer	2.69e-05	0.000164	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—lung cancer	2.69e-05	0.000164	CcSEcCtD
Sumatriptan—Pain—Methotrexate—lung cancer	2.67e-05	0.000163	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—lung cancer	2.66e-05	0.000162	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—lung cancer	2.65e-05	0.000161	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—lung cancer	2.65e-05	0.000161	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—lung cancer	2.64e-05	0.000161	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—lung cancer	2.63e-05	0.00016	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—lung cancer	2.62e-05	0.000159	CcSEcCtD
Sumatriptan—Nausea—Docetaxel—lung cancer	2.58e-05	0.000157	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—lung cancer	2.58e-05	0.000157	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—lung cancer	2.56e-05	0.000155	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—lung cancer	2.53e-05	0.000154	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—lung cancer	2.48e-05	0.000151	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—lung cancer	2.47e-05	0.00015	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—lung cancer	2.47e-05	0.00015	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.47e-05	0.00015	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—lung cancer	2.43e-05	0.000148	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—lung cancer	2.41e-05	0.000147	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—lung cancer	2.41e-05	0.000146	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—lung cancer	2.35e-05	0.000143	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—lung cancer	2.34e-05	0.000142	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—lung cancer	2.33e-05	0.000142	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—lung cancer	2.31e-05	0.000141	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—lung cancer	2.31e-05	0.000141	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—lung cancer	2.3e-05	0.00014	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—lung cancer	2.24e-05	0.000136	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—lung cancer	2.23e-05	0.000136	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—lung cancer	2.21e-05	0.000135	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—lung cancer	2.21e-05	0.000134	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—lung cancer	2.15e-05	0.000131	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—lung cancer	2.14e-05	0.00013	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—lung cancer	2.14e-05	0.00013	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—lung cancer	2.14e-05	0.00013	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—lung cancer	2.07e-05	0.000126	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—lung cancer	1.99e-05	0.000121	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—lung cancer	1.99e-05	0.000121	CcSEcCtD
Sumatriptan—Rash—Methotrexate—lung cancer	1.97e-05	0.00012	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—lung cancer	1.97e-05	0.00012	CcSEcCtD
Sumatriptan—Headache—Methotrexate—lung cancer	1.96e-05	0.000119	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—lung cancer	1.94e-05	0.000118	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—lung cancer	1.91e-05	0.000116	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—lung cancer	1.86e-05	0.000113	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—lung cancer	1.85e-05	0.000113	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—lung cancer	1.79e-05	0.000109	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—lung cancer	1.72e-05	0.000105	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—lung cancer	1.71e-05	0.000104	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—lung cancer	1.7e-05	0.000104	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—lung cancer	1.7e-05	0.000103	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—lung cancer	1.61e-05	9.78e-05	CcSEcCtD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL8—lung cancer	5.76e-06	9.8e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.76e-06	9.79e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CREBBP—lung cancer	5.75e-06	9.79e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CG—lung cancer	5.75e-06	9.78e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—lung cancer	5.72e-06	9.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—lung cancer	5.69e-06	9.69e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HES1—lung cancer	5.69e-06	9.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—lung cancer	5.67e-06	9.65e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAP2K1—lung cancer	5.67e-06	9.65e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MAPK3—lung cancer	5.67e-06	9.64e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CD—lung cancer	5.63e-06	9.58e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PIK3CA—lung cancer	5.58e-06	9.49e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RAF1—lung cancer	5.58e-06	9.48e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CB—lung cancer	5.56e-06	9.46e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAP2K1—lung cancer	5.55e-06	9.45e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2E1—lung cancer	5.52e-06	9.39e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CD—lung cancer	5.52e-06	9.38e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—lung cancer	5.52e-06	9.38e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MYC—lung cancer	5.51e-06	9.38e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—lung cancer	5.51e-06	9.37e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGFR1—lung cancer	5.51e-06	9.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—lung cancer	5.51e-06	9.36e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—POMC—lung cancer	5.47e-06	9.3e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PIK3CA—lung cancer	5.46e-06	9.29e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NQO1—lung cancer	5.46e-06	9.29e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CD—lung cancer	5.46e-06	9.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CB—lung cancer	5.44e-06	9.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—lung cancer	5.43e-06	9.23e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—lung cancer	5.4e-06	9.19e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—lung cancer	5.39e-06	9.17e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—lung cancer	5.39e-06	9.16e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CREBBP—lung cancer	5.33e-06	9.06e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOA1—lung cancer	5.24e-06	8.91e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL8—lung cancer	5.23e-06	8.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.21e-06	8.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB3—lung cancer	5.2e-06	8.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KDR—lung cancer	5.19e-06	8.83e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CB—lung cancer	5.15e-06	8.77e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—lung cancer	5.11e-06	8.69e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—lung cancer	5.1e-06	8.67e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PIK3CA—lung cancer	5.07e-06	8.62e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CD—lung cancer	5.05e-06	8.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MDM2—lung cancer	5.05e-06	8.59e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RAF1—lung cancer	5.03e-06	8.56e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—lung cancer	5e-06	8.5e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—lung cancer	4.99e-06	8.48e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—lung cancer	4.98e-06	8.47e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB2—lung cancer	4.98e-06	8.46e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PIK3CA—lung cancer	4.96e-06	8.44e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MDM2—lung cancer	4.94e-06	8.41e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RAF1—lung cancer	4.93e-06	8.38e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—STK11—lung cancer	4.92e-06	8.37e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MTOR—lung cancer	4.91e-06	8.35e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CB—lung cancer	4.91e-06	8.35e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB2—lung cancer	4.87e-06	8.29e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGFR1—lung cancer	4.84e-06	8.23e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CB—lung cancer	4.81e-06	8.18e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MTOR—lung cancer	4.81e-06	8.18e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—lung cancer	4.81e-06	8.17e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CG—lung cancer	4.78e-06	8.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIT—lung cancer	4.78e-06	8.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APC—lung cancer	4.78e-06	8.13e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—NRAS—lung cancer	4.78e-06	8.13e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—lung cancer	4.76e-06	8.1e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.76e-06	8.09e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGF—lung cancer	4.73e-06	8.04e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL8—lung cancer	4.72e-06	8.03e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—lung cancer	4.71e-06	8.02e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—lung cancer	4.69e-06	7.97e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PIK3CA—lung cancer	4.68e-06	7.96e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL8—lung cancer	4.62e-06	7.86e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOA1—lung cancer	4.6e-06	7.82e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—lung cancer	4.59e-06	7.81e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—lung cancer	4.58e-06	7.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—MAPK3—lung cancer	4.58e-06	7.79e-05	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—lung cancer	4.56e-06	7.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KDR—lung cancer	4.56e-06	7.75e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—lung cancer	4.55e-06	7.75e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—POMC—lung cancer	4.55e-06	7.74e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—lung cancer	4.53e-06	7.7e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—lung cancer	4.52e-06	7.68e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—lung cancer	4.51e-06	7.67e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—lung cancer	4.49e-06	7.64e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—lung cancer	4.49e-06	7.63e-05	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—lung cancer	4.46e-06	7.59e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—lung cancer	4.45e-06	7.57e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6R—lung cancer	4.44e-06	7.55e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CREBBP—lung cancer	4.43e-06	7.54e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—lung cancer	4.43e-06	7.54e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—lung cancer	4.42e-06	7.52e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—lung cancer	4.42e-06	7.51e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CB—lung cancer	4.4e-06	7.49e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—lung cancer	4.4e-06	7.48e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—lung cancer	4.39e-06	7.47e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—lung cancer	4.39e-06	7.46e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—lung cancer	4.36e-06	7.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—lung cancer	4.36e-06	7.41e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—lung cancer	4.33e-06	7.37e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—lung cancer	4.31e-06	7.32e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—lung cancer	4.3e-06	7.31e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—lung cancer	4.27e-06	7.26e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDKN1A—lung cancer	4.25e-06	7.23e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—lung cancer	4.25e-06	7.22e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—lung cancer	4.24e-06	7.22e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TYMS—lung cancer	4.23e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAP2K1—lung cancer	4.23e-06	7.2e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CD—lung cancer	4.2e-06	7.15e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CG—lung cancer	4.2e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIT—lung cancer	4.2e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APC—lung cancer	4.2e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—NRAS—lung cancer	4.2e-06	7.14e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTM1—lung cancer	4.18e-06	7.12e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—lung cancer	4.18e-06	7.11e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDKN1A—lung cancer	4.16e-06	7.08e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PIK3CA—lung cancer	4.16e-06	7.08e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—lung cancer	4.16e-06	7.07e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGF—lung cancer	4.15e-06	7.06e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—lung cancer	4.15e-06	7.05e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—lung cancer	4.14e-06	7.04e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—lung cancer	4.11e-06	7e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—lung cancer	4.11e-06	6.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—lung cancer	4.05e-06	6.89e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—lung cancer	4.05e-06	6.88e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—MAPK3—lung cancer	4.02e-06	6.84e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—POMC—lung cancer	4e-06	6.8e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP1A1—lung cancer	3.97e-06	6.75e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—lung cancer	3.96e-06	6.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—lung cancer	3.95e-06	6.71e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SRC—lung cancer	3.94e-06	6.69e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ERCC2—lung cancer	3.93e-06	6.69e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—lung cancer	3.92e-06	6.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6R—lung cancer	3.9e-06	6.63e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CREBBP—lung cancer	3.89e-06	6.62e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SRC—lung cancer	3.85e-06	6.55e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VEGFA—lung cancer	3.83e-06	6.52e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—lung cancer	3.82e-06	6.5e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—lung cancer	3.82e-06	6.5e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—lung cancer	3.81e-06	6.47e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—lung cancer	3.8e-06	6.46e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NRAS—lung cancer	3.79e-06	6.44e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PIK3CA—lung cancer	3.78e-06	6.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MDM2—lung cancer	3.77e-06	6.4e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VEGFA—lung cancer	3.75e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RAF1—lung cancer	3.75e-06	6.38e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—lung cancer	3.72e-06	6.32e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAP2K1—lung cancer	3.71e-06	6.32e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB2—lung cancer	3.71e-06	6.31e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NRAS—lung cancer	3.71e-06	6.31e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CD—lung cancer	3.69e-06	6.28e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MTOR—lung cancer	3.66e-06	6.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CB—lung cancer	3.66e-06	6.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	3.65e-06	6.22e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—lung cancer	3.63e-06	6.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MAPK3—lung cancer	3.63e-06	6.17e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—lung cancer	3.61e-06	6.14e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MAPK3—lung cancer	3.55e-06	6.04e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MYC—lung cancer	3.53e-06	6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL8—lung cancer	3.52e-06	5.99e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—lung cancer	3.5e-06	5.95e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MYC—lung cancer	3.45e-06	5.87e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—lung cancer	3.45e-06	5.87e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOA1—lung cancer	3.4e-06	5.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—lung cancer	3.4e-06	5.78e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PIK3CA—lung cancer	3.39e-06	5.77e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—lung cancer	3.38e-06	5.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—lung cancer	3.37e-06	5.73e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—lung cancer	3.36e-06	5.72e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—lung cancer	3.35e-06	5.69e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PIK3CA—lung cancer	3.32e-06	5.64e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MDM2—lung cancer	3.31e-06	5.62e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RAF1—lung cancer	3.29e-06	5.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—lung cancer	3.28e-06	5.58e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—lung cancer	3.27e-06	5.57e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB2—lung cancer	3.26e-06	5.54e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—lung cancer	3.26e-06	5.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MTOR—lung cancer	3.22e-06	5.47e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CB—lung cancer	3.22e-06	5.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—lung cancer	3.19e-06	5.43e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—lung cancer	3.18e-06	5.42e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDKN1A—lung cancer	3.17e-06	5.4e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—lung cancer	3.17e-06	5.38e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PIK3CA—lung cancer	3.14e-06	5.34e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CG—lung cancer	3.11e-06	5.28e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL8—lung cancer	3.09e-06	5.26e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—lung cancer	3.09e-06	5.25e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—lung cancer	3.07e-06	5.22e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—lung cancer	3.02e-06	5.13e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PIK3CA—lung cancer	2.99e-06	5.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—lung cancer	2.99e-06	5.08e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—lung cancer	2.96e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—POMC—lung cancer	2.96e-06	5.03e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—lung cancer	2.95e-06	5.02e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—lung cancer	2.94e-06	5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SRC—lung cancer	2.94e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PIK3CA—lung cancer	2.93e-06	4.99e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.9e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—lung cancer	2.9e-06	4.93e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CREBBP—lung cancer	2.88e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—lung cancer	2.88e-06	4.9e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—lung cancer	2.87e-06	4.89e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VEGFA—lung cancer	2.86e-06	4.86e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—lung cancer	2.84e-06	4.82e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—lung cancer	2.83e-06	4.81e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NRAS—lung cancer	2.82e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—lung cancer	2.8e-06	4.75e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDKN1A—lung cancer	2.79e-06	4.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—lung cancer	2.78e-06	4.73e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—lung cancer	2.77e-06	4.71e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—lung cancer	2.77e-06	4.71e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CD—lung cancer	2.73e-06	4.65e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—lung cancer	2.71e-06	4.61e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—lung cancer	2.71e-06	4.61e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MAPK3—lung cancer	2.7e-06	4.6e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—lung cancer	2.7e-06	4.59e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PIK3CA—lung cancer	2.68e-06	4.57e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—lung cancer	2.65e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—lung cancer	2.65e-06	4.51e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MYC—lung cancer	2.63e-06	4.47e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—lung cancer	2.6e-06	4.41e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SRC—lung cancer	2.58e-06	4.38e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—lung cancer	2.57e-06	4.38e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—lung cancer	2.57e-06	4.37e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VEGFA—lung cancer	2.51e-06	4.27e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—lung cancer	2.49e-06	4.23e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NRAS—lung cancer	2.48e-06	4.22e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—lung cancer	2.45e-06	4.16e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—lung cancer	2.43e-06	4.13e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—lung cancer	2.39e-06	4.07e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CB—lung cancer	2.38e-06	4.05e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MAPK3—lung cancer	2.37e-06	4.04e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—lung cancer	2.37e-06	4.03e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—lung cancer	2.36e-06	4.01e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MYC—lung cancer	2.31e-06	3.93e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—lung cancer	2.26e-06	3.84e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.23e-06	3.8e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—lung cancer	2.19e-06	3.73e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—lung cancer	2.16e-06	3.67e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—lung cancer	2.13e-06	3.63e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—lung cancer	2.07e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—lung cancer	2.06e-06	3.5e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—lung cancer	1.98e-06	3.36e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—lung cancer	1.96e-06	3.34e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.96e-06	3.33e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—lung cancer	1.9e-06	3.23e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—lung cancer	1.82e-06	3.1e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—lung cancer	1.81e-06	3.09e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—lung cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—lung cancer	1.6e-06	2.72e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PIK3CA—lung cancer	1.45e-06	2.47e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—lung cancer	1.19e-06	2.02e-05	CbGpPWpGaD
